Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024 Health House International parent Melodiol Global Health reported a full-year loss of more than A$52 million […]
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Health House founder Paul Mavor ‘back in the pharmacy game’ by Martin Lane November 6, 2023November 8, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Health House International delivers profitable quarter for new owner Melodiol by Martin Lane October 16, 2023October 18, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023
Melodiol reports strong start to Q3 as Health House acquisition begins to bed down by Steve Jones July 19, 2023July 20, 2023
Creso hits back after ASX questions firm’s ability to remain listed by Steve Jones May 16, 2023May 17, 2023
Company news: Health House; Little Green Pharma; Incannex; Emyria by Steve Jones and Martin Lane April 19, 2023April 19, 2023